155 related articles for article (PubMed ID: 29564913)
41. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
42. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
[TBL] [Abstract][Full Text] [Related]
43. The Common miRNA Signatures Associated with Mitochondrial Dysfunction in Different Muscular Dystrophies.
Aksu-Menges E; Akkaya-Ulum YZ; Dayangac-Erden D; Balci-Peynircioglu B; Yuzbasioglu A; Topaloglu H; Talim B; Balci-Hayta B
Am J Pathol; 2020 Oct; 190(10):2136-2145. PubMed ID: 32650001
[TBL] [Abstract][Full Text] [Related]
44. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
45. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).
Nadarajah VD; van Putten M; Chaouch A; Garrood P; Straub V; Lochmüller H; Ginjaar HB; Aartsma-Rus AM; van Ommen GJ; den Dunnen JT; 't Hoen PA
Neuromuscul Disord; 2011 Aug; 21(8):569-78. PubMed ID: 21724396
[TBL] [Abstract][Full Text] [Related]
46. Identification of immune-related features involved in Duchenne muscular dystrophy: A bidirectional transcriptome and proteome-driven analysis.
Wu X; Dong N; Yu L; Liu M; Jiang J; Tang T; Zhao H; Fang Q
Front Immunol; 2022; 13():1017423. PubMed ID: 36483550
[TBL] [Abstract][Full Text] [Related]
47. Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy.
Meng Q; Zhang J; Zhong J; Zeng D; Lan D
Front Neurol; 2022; 13():921785. PubMed ID: 35873767
[TBL] [Abstract][Full Text] [Related]
48. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
49. Fibronectin is a serum biomarker for Duchenne muscular dystrophy.
Cynthia Martin F; Hiller M; Spitali P; Oonk S; Dalebout H; Palmblad M; Chaouch A; Guglieri M; Straub V; Lochmüller H; Niks EH; Verschuuren JJ; Aartsma-Rus A; Deelder AM; van der Burgt YE; 't Hoen PA
Proteomics Clin Appl; 2014 Apr; 8(3-4):269-78. PubMed ID: 24458521
[TBL] [Abstract][Full Text] [Related]
50. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
51. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
[TBL] [Abstract][Full Text] [Related]
52. Expression of microRNAs in basal cell carcinoma.
Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
[TBL] [Abstract][Full Text] [Related]
53. Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne.
Thangarajh M; Zhang A; Gill K; Ressom HW; Li Z; Varghese RS; Hoffman EP; Nagaraju K; Hathout Y; Boca SM
PLoS One; 2019; 14(7):e0219507. PubMed ID: 31310630
[TBL] [Abstract][Full Text] [Related]
54. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
56. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
57. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
58. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
59. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.
Bier A; Berenstein P; Kronfeld N; Morgoulis D; Ziv-Av A; Goldstein H; Kazimirsky G; Cazacu S; Meir R; Popovtzer R; Dori A; Brodie C
Biomaterials; 2018 Aug; 174():67-78. PubMed ID: 29783118
[TBL] [Abstract][Full Text] [Related]
60. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome.
Luo Y; Wang C; Chen X; Zhong T; Cai X; Chen S; Shi Y; Hu J; Guan X; Xia Z; Wang J; Zen K; Zhang CY; Zhang C
Clin Chem; 2013 Apr; 59(4):658-66. PubMed ID: 23344497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
